- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/42 - Cancer antigens
Patent holdings for IPC class A61K 40/42
Total number of patents in this class: 3130
10-year publication summary
|
7
|
12
|
22
|
62
|
170
|
286
|
183
|
106
|
853
|
888
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20902 |
77 |
| The Trustees of the University of Pennsylvania | 4437 |
77 |
| Memorial Sloan-Kettering Cancer Center | 2056 |
61 |
| Kite Pharma, Inc. | 458 |
46 |
| Iovance Biotherapeutics, Inc. | 410 |
45 |
| Board of Regents, The University of Texas System | 6172 |
44 |
| Juno Therapeutics, Inc. | 503 |
43 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
38 |
| Autolus Limited | 272 |
35 |
| Novartis AG | 10169 |
34 |
| Dana-Farber Cancer Institute, Inc. | 2671 |
33 |
| Immunitybio, Inc. | 514 |
33 |
| City of Hope | 1048 |
32 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1037 |
30 |
| The Board of Trustees of the Leland Stanford Junior University | 6711 |
29 |
| Memorial Hospital for Cancer and Allied Diseases | 428 |
28 |
| Sloan-Kettering Institute for Cancer Research | 637 |
27 |
| Regeneron Pharmaceuticals, Inc. | 4810 |
26 |
| Allogene Therapeutics, Inc. | 167 |
26 |
| Janssen Biotech, Inc. | 1794 |
24 |
| Other owners | 2342 |